Abstract
Blood monitoring of therapeutic drugs is frequently used in clinical settings for the purpose of optimizing drug therapy. Psychotropic and psychiatric medications are used to treat a variety of mental health conditions, including depression, anxiety, bipolar disorder, and schizophrenia. Saliva is gaining increasing attention as a bioanalytical sample matrix for drug monitoring, including monitoring of psychotropic medications. Much of the advantages of saliva sampling come from the easy and noninvasive nature of saliva collection, which has clear advantages over blood draws, especially in pediatric populations or when frequent monitoring is required. Great improvements in the development of accurate and reliable methods for sample collection and highly sensitive and specific analytical methods for saliva testing of drugs have been observed in recent years. This chapter will review studies supporting the applicability of saliva for monitoring of psychotropic drugs, including antidepressants, mood stabilizers, and antipsychotic drugs. Further, this chapter will cover the main technological advances over the last decade, which have made oral fluid analysis of drugs possible.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
al Za’abi, M., Deleu, D., & Batchelor, C. (2003). Salivary free concentrations of anti-epileptic drugs: An evaluation in a routine clinical setting. Acta Neurologica Belgica, 103(1), 19–23.
Baptista, T. (1999). Body weight gain induced by antipsychotic drugs: Mechanisms and management. Acta Psychiatrica Scandinavica, 100(1), 3–16.
Baptista, T., Kin, N. M., Beaulieu, S., & de Baptista, E. A. (2002). Obesity and related metabolic abnormalities during antipsychotic drug administration: Mechanisms, management and research perspectives. Pharmacopsychiatry, 35(6), 205–219.
Belostotsky, V., Adaway, J., Keevil, B. G., Cohen, D. R., & Webb, N. J. (2011). Measurement of saliva tacrolimus levels in pediatric renal transplant recipients. Pediatric Nephrology, 26(1), 133–138.
Benard, V., Vaiva, G., Masson, M., & Geoffroy, P. A. (2016). Lithium and suicide prevention in bipolar disorder. Encephale, 42(3), 234–241.
Ben-Aryeh, H., Laor, R., Szargel, R., Gutman, D., Naon, H., Pascal, M., & Hefetz, A. (1984). Saliva for monitoring of patients with primary affective disorders. Israel Journal of Medical Sciences, 20(3), 197–201.
Bowden, C. L., Houston, J. P., Shulman, R. S., & Clothier, J. M. (1982). Clinical utility of salivary lithium concentration. International Pharmacopsychiatry, 17(2), 104–113.
Bymaster, F. P., Calligaro, D. O., Falcone, J. F., Marsh, R. D., Moore, N. A., Tye, N. C., … Wong, T. (1996). Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology, 14, 87–96.
Cade, J. F. (1949). Lithium salts in the treatment of psychotic excitement. The Medical Journal of Australia, 2(10), 349–352.
Chapoteau, E., Czech, B. P., Zazulak, W., & Kumar, A. (1992). First practical colorimetric assay of lithium in serum. Clinical Chemistry, 38(9), 1654–1657.
Chicharro, J. L., Lucia, A., Perez, M., Vaquero, A. F., & Urena, R. (1998). Saliva composition and exercise. Sports Medicine, 26(1), 17–27.
Cooper, T. B., Bark, N., & Simpson, G. M. (1981). Prediction of steady state plasma and saliva levels of desmethylimipramine using a single dose, single time point procedure. Psychopharmacology, 74(2), 115–121.
Danielyan, A., & Kowatch, R. A. (2005). Management options for bipolar disorder in children and adolescents. Paediatric Drugs, 7(5), 277–294.
Doshi, B. S., Rout, S. J., & Kulkarni, R. D. (1983). Absorption & urinary & salivary excretion of lithium after oral administration. The Indian Journal of Medical Research, 78, 708–712.
Dumortier, G., Lochu, A., Zerrouk, A., Van Nieuwenhuyse, V., Colen de Melo, P., Roche Rabreau, D., & Degrassat, K. (1998). Whole saliva and plasma levels of clozapine and desmethylclozapine. Journal of Clinical Pharmacy and Therapeutics, 23(1), 35–40.
Dwivedi, R., Gupta, Y. K., Singh, M., Joshi, R., Tiwari, P., Kaleekal, T., & Tripathi, M. (2015). Correlation of saliva and serum free valproic acid concentrations in persons with epilepsy. Seizure, 25, 187–190.
Dwivedi, R., Singh, M., Kaleekal, T., Gupta, Y. K., & Tripathi, M. (2016). Concentration of antiepileptic drugs in persons with epilepsy: A comparative study in serum and saliva. The International Journal of Neuroscience, 126(11), 972–978.
Dysken, M. W., Johnson, S. B., Holden, L., Kuskowski, M., Ofstehage, J., Skare, S., & Vatassery, G. (1992). Haloperidol and reduced haloperidol in saliva and blood. J Clin Psychopharmacol, 12(3), 186-190.
Dziomba, S., Kowalski, P., & Baczek, T. (2012). Micelle to solvent stacking of tricyclic psychiatric drugs in capillary electrophoresis. Journal of Pharmaceutical and Biomedical Analysis, 62, 149–154.
Dziurkowska, E., & Wesolowski, M. (2013). Simultaneous quantitation of venlafaxine and its main metabolite, O-desmethylvenlafaxine, in human saliva by HPLC. Journal of Separation Science, 36(11), 1726–1733.
Ebert, K., Maurice, E., Lukacin, R., Fleischhaker, C., Schulz, E., Ebert, D., & Clement, H. W. (2018). Serum and saliva concentrations of venlafaxine, O-Desmethylvenlafaxine, Quetiapine, and citalopram in psychiatric patients. Therapeutic Drug Monitoring, 40(3), 351–355.
El-Mallakh, R. S., Linder, M., Valdes, R., & Looney, S. (2004). Dialysis of saliva improves accuracy of saliva lithium determinations. Bipolar Disorders, 6(1), 87–89.
Fisher, D. S., Partridge, S. J., Handley, S. A., Couchman, L., Morgan, P. E., & Flanagan, R. J. (2013). LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood. Forensic Science International, 229(1–3), 145–150.
Fisher, D. S., Partridge, S. J., Handley, S. A., & Flanagan, R. J. (2013). Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum. Forensic Science International, 229(1–3), 151–156.
Fisher, D. S., van Schalkwyk, G. I., Seedat, S., Curran, S. R., & Flanagan, R. J. (2013). Plasma, oral fluid, and whole-blood distribution of antipsychotics and metabolites in clinical samples. Therapeutic Drug Monitoring, 35(3), 345–351.
Granger, D. A., Fortunato, C. K., Beltzer, E. K., Virag, M., Bright, M. A., & Out, D. (2012). Focus on methodology: Salivary bioscience and research on adolescence: An integrated perspective. Journal of Adolescence, 35(4), 1081–1095.
Greenaway, C., Ratnaraj, N., Sander, J. W., & Patsalos, P. N. (2011). Saliva and serum lacosamide concentrations in patients with epilepsy. Epilepsia, 52(2), 258–263.
Gupta, S., Droney, T., Al-Samarrai, S., Keller, P., & Frank, B. (1999). Olanzapine: Weight gain and therapeutic efficacy. Journal of Clinical Psychopharmacology, 19(3), 273–275.
Huang, H. C., Liu, C. H., Lan, T. H., Hu, T. M., Chiu, H. J., Wu, Y. C., & Tseng, Y. L. (2007). Detection and quantification of aripiprazole and its metabolite, dehydroaripiprazole, by gas chromatography-mass spectrometry in blood samples of psychiatric patients. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 856(1–2), 57–61.
Huestis, M. A., & Cone, E. J. (2007). Methamphetamine disposition in oral fluid, plasma, and urine. Annals of the New York Academy of Sciences, 1098, 104–121.
Humphrey, S. P., & Williamson, R. T. (2001). A review of saliva: Normal composition, flow, and function. The Journal of Prosthetic Dentistry, 85(2), 162–169.
Incecayir, T., Agabeyoglu, I., & Gucuyener, K. (2007). Comparison of plasma and saliva concentrations of lamotrigine in healthy volunteers. Arzneimittel-Forschung, 57(8), 517–521.
Iqbal, M. M., Rahman, A., Husain, Z., Mahmud, S. Z., Ryan, W. G., & Feldman, J. M. (2003). Clozapine: A clinical review of adverse effects and management. Annals of Clinical Psychiatry, 15(1), 33–48.
Jain, A. K., Kelwala, S., & Gershon, S. (1988). Antipsychotic drugs in schizophrenia: current issues. International Clinical Psychopharmacology, 3, 1–30.
Jain, T., Bhandari, A., Ram, V., Sharma, S., Parakh, M., & Parakh, M. C. (2011). Correlation of haloperidol levels between saliva and plasma of acutely ill schizophrenic patients. Clinical Biochemistry, 44(8–9), 675–680.
Jann, M. W. (1991). Clozapine. Pharmacotherapy, 11, 179–195.
Kerwin, R., & Taylor, D. (1996). Antipsychotics – a review of the current status and clinical potential. CNS Drugs, 6, 71–82.
Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., … Kendler, K. S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 51(1), 8–19.
Khare, C. B., Sankaranarayanan, A., Goel, A., Khandelwal, S. K., & Srinivasa Murthy, R. (1983). Saliva lithium levels for monitoring lithium prophylaxis of manic depressive psychosis. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 21(9), 451–453.
Kiang, T. K., & Ensom, M. H. (2016). A qualitative review on the pharmacokinetics of antibiotics in saliva: Implications on clinical pharmacokinetic monitoring in humans. Clinical Pharmacokinetics, 55(3), 313–358.
Laux, G., Baumann, P., & Hiemke, C. (2007). Therapeutic drug monitoring of antidepressants – clinical aspects. Journal of Neural Transmission (Suppl), 72, 261–267.
Li, J., Zhao, F., & Ju, H. (2006). Simultaneous determination of psychotropic drugs in human urine by capillary electrophoresis with electrochemiluminescence detection. Analytica Chimica Acta, 575(1), 57–61.
Liu, J., & Duan, Y. (2012). Saliva: a potential media for disease diagnostics and monitoring. Oral Oncology, 48(7), 569–577.
MacKichan, J. J., Duffner, P. K., & Cohen, M. E. (1981). Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients. British Journal of Clinical Pharmacology, 12(1), 31–37.
Mandrioli, R., Mercolini, L., Lateana, D., Boncompagni, G., & Raggi, M. A. (2011). Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 879(2), 167–173.
McKeage, M. J., & Maling, T. J. (1989). Saliva lithium: A poor predictor of plasma and erythrocyte levels. The New Zealand Medical Journal, 102(878), 559–560.
Mohamed, R., Campbell, J. L., Cooper-White, J., Dimeski, G., & Punyadeera, C. (2012). The impact of saliva collection and processing methods on CRP, IgE, and myoglobin immunoassays. Clinical and Translational Medicine, 1(1), 19.
Montoya, A., Perez Sanchez Toledo, J., Gilaberte, I., Gonzalez-Pinto, A., Haro, J. M., Vieta, E., & Tohen, M. (2007). Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM study. Actas Españolas de PsiquiatrÃa, 35(5), 315–322.
Moody, J. P. (1999). Biologic variation of serum and salivary lithium. Therapeutic Drug Monitoring, 21(1), 97–101.
Murru, A., Pacchiarotti, I., Amann, B. L., Nivoli, A. M., Vieta, E., & Colom, F. (2013). Treatment adherence in bipolar I and schizoaffective disorder, bipolar type. Journal of Affective Disorders, 151(3), 1003–1008.
Murru, A., Torra, M., Callari, A., Pacchiarotti, I., Romero, S., Gonzalez de la Presa, B., … Colom, F. (2017). A study on the bioequivalence of lithium and valproate salivary and blood levels in the treatment of bipolar disorder. European Neuropsychopharmacology, 27(8), 744–750.
Nataraj, G. S., & Bhat, V. K. (1981). Reliability of saliva lithium level-a prospective study. Indian Journal of Psychiatry, 23(2), 115–119.
Ng, F., Hallam, K., Lucas, N., & Berk, M. (2007). The role of lamotrigine in the management of bipolar disorder. Neuropsychiatric Disease and Treatment, 3(4), 463–474.
Obach, R., Borja, J., Prunonosa, J., Valles, J. M., Torrent, J., Izquierdo, I., & Jane, F. (1988). Lack of correlation between lithium pharmacokinetic parameters obtained from plasma and saliva. Therapeutic Drug Monitoring, 10(3), 265–268.
Petruczynik, A., Wroblewski, K., Szultka-Mlynska, M., Buszewski, B., Karakula-Juchnowicz, H., Gajewski, J., … Waksmundzka-Hajnos, M. (2016). Determination of some psychotropic drugs in serum and saliva samples by HPLC-DAD and HPLC MS. Journal of Pharmaceutical and Biomedical Analysis, 127, 68–80.
Pi, E. H., Tran-Johnson, T. K., Gray, G. E., Walker, N. R., Suckow, R. F., & Cooper, T. B. (1991). Saliva and plasma desipramine levels in Asian and Caucasian volunteers. Psychopharmacology Bulletin, 27(3), 281–284.
Post, R. M., Denicoff, K. D., Frye, M. A., Dunn, R. T., Leverich, G. S., Osuch, E., & Speer, A. (1998). A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century. Neuropsychobiology, 38(3), 152–166.
Pujadas, M., Pichini, S., Civit, E., Santamarina, E., Perez, K., & de la Torre, R. (2007). A simple and reliable procedure for the determination of psychoactive drugs in oral fluid by gas chromatography-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 44(2), 594–601.
Rosenthal, E., Hoffer, E., Ben-Aryeh, H., Badarni, S., Benderly, A., & Hemli, Y. (1995). Use of saliva in home monitoring of carbamazepine levels. Epilepsia, 36(1), 72–74.
Rosman, A. W., Sczupak, C. A., & Pakes, G. E. (1980). Correlation between saliva and serum lithium levels in manic-depressive patients. American Journal of Hospital Pharmacy, 37(4), 514–518.
Ryan, M., Grim, S. A., Miles, M. V., Tang, P. H., Fakhoury, T. A., Strawsburg, R. H., … Baumann, R. J. (2003). Correlation of lamotrigine concentrations between serum and saliva. Pharmacotherapy, 23(12), 1550–1557.
Sankaranarayanan, A., Goel, A., & Pant, V. L. (1985). Variation in the relationship between serum and saliva lithium levels. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 23, 365–366.
Sasaki, C., Shinozuka, T., Murakami, C., Irie, W., Maeda, K., Watanabe, T., … Kurihara, K. (2013). Simultaneous determination of 5 psychotropic drugs of various types in an autopsy case of acute multiple drug poisoning. Forensic Science International, 227(1–3), 90–94.
Schramm, W., Annesley, T. M., Siegel, G. J., Sackellares, J. C., & Smith, R. H. (1991). Measurement of phenytoin and carbamazepine in an ultrafiltrate of saliva. Therapeutic Drug Monitoring, 13(5), 452–460.
Serdarevic, N., Kozjek, F., & Malesic, I. (2006). Saliva and serum lithium monitoring in hospitalized patients and possibility to replace serum to saliva. Bosnian Journal of Basic Medical Sciences, 6(4), 32–35.
Shetty, S. J., Desai, P. B., Patil, N. M., & Nayak, R. B. (2012). Relationship between serum lithium, salivary lithium, and urinary lithium in patients on lithium therapy. Biological Trace Element Research, 147(1–3), 59–62.
Shorter, E. (2009). The history of lithium therapy. Bipolar Disorders, 11(Suppl 2), 4–9.
Spencer, E. K., Campbell, M., Adams, P., Perry, R., Choroco, M. C., Padron-Gayol, M., & Small, A. M. (1990). Saliva and serum lithium monitoring in hospitalized children. Psychopharmacology Bulletin, 26(2), 239–243.
Takai, N., Eto, K., Uchihashi, K., Yamaguchi, M., & Nishikawa, Y. (2006). Correlation of haloperidol levels between submandibular saliva and brain in the rat. Archives of Oral Biology, 51(7), 567–572.
Thomas, T., Stansifer, L., & Findling, R. L. (2011). Psychopharmacology of pediatric bipolar disorders in children and adolescents. Pediatric Clinics of North America, 58(1), 173–187. xii.
Tonic-Ribarska, J., Haxhiu, A., Sterjev, Z., Kiteva, G., Suturkova, L., & Trajkovic-Jolevska, S. (2012). Development and validation of a bioanalytical LC-UV method with solid-phase extraction for determination of valproic acid in saliva. Acta Pharmaceutica, 62(2), 211–220.
Tsiropoulos, I., Kristensen, O., & Klitgaard, N. A. (2000). Saliva and serum concentration of lamotrigine in patients with epilepsy. Therapeutic Drug Monitoring, 22(5), 517–521.
Vitiello, B., Behar, D., Malone, R., Delaney, M. A., Ryan, P. J., & Simpson, G. M. (1988). Pharmacokinetics of lithium carbonate in children. Journal of Clinical Psychopharmacology, 8(5), 355-359.
Xiong, C., Ruan, J., Cai, Y., & Tang, Y. (2009). Extraction and determination of some psychotropic drugs in urine samples using dispersive liquid-liquid microextraction followed by high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis, 49(2), 572–578.
Yamazumi, S., & Miura, S. (1981). Haloperidol concentrations in saliva and serum: Determination by the radioimmunoassay method. International Pharmacopsychiatry, 16(3), 174–183.
Yan, W., Apweiler, R., Balgley, B. M., Boontheung, P., Bundy, J. L., Cargile, B. J., … Wong, D. T. (2009). Systematic comparison of the human saliva and plasma proteomes. Proteomics Clinical Applications, 3(1), 116–134.
Zalsman, G., Hawton, K., Wasserman, D., van Heeringen, K., Arensman, E., Sarchiapone, M., … Zohar, J. (2016). Suicide prevention strategies revisited: 10-year systematic review. Lancet Psychiatry, 3(7), 646–659.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Thomas, E.A. (2020). Therapeutic Drug Monitoring in Saliva. In: Granger, D., Taylor, M. (eds) Salivary Bioscience. Springer, Cham. https://doi.org/10.1007/978-3-030-35784-9_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-35784-9_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-35783-2
Online ISBN: 978-3-030-35784-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)